Author:
Qian Kewen,Li Guangyao,Zhang Shuyi,Zou Yitan,Ai Hongru,Zheng Xinya,Fu Wenyan,Lei Changhai,Hu Shi
Funder
National Natural Science Foundation of China
Reference223 articles.
1. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer research,1998
2. Antibody drug conjugate: the “biological missile” for targeted cancer therapy;Fu;Signal Transduction and Targeted Therapy,2022
3. Catumaxomab: clinical development and future directions;Linke;mAbs,2010
4. Development of therapeutic antibodies for the treatment of diseases;Wang;Molecular biomedicine,2022
5. Development of therapeutic antibodies for the treatment of diseases;Lu;Journal of biomedical science,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献